THC Farmaceuticals Inc. | Income Statement
Fiscal year is October-September. All values USD Thousands.
2012
2013
2014
2015
2016
2017
2018
Sales/Revenue
30.60
21.60
19.00
13.70
17.10
12.90
12.20
SG&A Expense
52.70
40.20
42.50
205.70
152.60
19.60
26.50
EBIT
23.50
19.60
24.00
192.60
136.10
7.30
15.20
Unusual Expense
9.80
-
-
801.10
-
-
-
Non Operating Income/Expense
4.80
-
-
-
-
-
-
Interest Expense
1.60
4.30
6.70
0.60
-
-
-
Pretax Income
39.70
23.80
30.70
994.20
136.10
7.30
15.20
Consolidated Net Income
39.70
23.80
30.70
994.20
136.10
7.30
15.20
Net Income
39.70
23.80
30.70
994.20
136.10
7.30
15.20
Net Income After Extraordinaries
39.70
23.80
30.70
994.20
136.10
7.30
15.20
Net Income Available to Common
39.70
23.80
30.70
994.20
136.10
7.30
15.20
EPS (Basic)
0.00
0.00
0.00
0.08
0.01
0.00
-
Basic Shares Outstanding
8,968.00
8,968.00
8,968.00
13,243
15,131.60
15,131.60
15,245.60
EPS (Diluted)
0.00
0.00
0.00
0.08
0.01
0.00
-
Diluted Shares Outstanding
8,968.00
8,968.00
8,968.00
13,243
15,131.60
15,131.60
15,245.60
EBITDA
22.10
18.50
23.40
191.90
135.50
6.70
14.30
About THC Farmaceuticals
View Profile
